Therapy Areas: Infectious Diseases
Aptamer Group launches Optimer-based Ebola diagnostic programme
8 July 2026 - Biotechnology company Aptamer Group plc (AIM: APTA) announced on Wednesday that it has commenced development of Optimer binders for a potential rapid diagnostic test targeting the Bundib...
Physiomics secures new contracts worth over GBP200,000
8 July 2026 - Physiomics plc (AIM: PYC), a mathematical modelling, data science and biostatistics company, declared on Wednesday that it has secured multiple contract awards with a combined estimated ...
EDX Medical to provide molecular profiling services to Astron Health
8 July 2026 - EDX Medical Group plc (LSE: EDX) announced on Wednesday that it has been appointed by Astron Health Ltd to provide molecular profiling products and services in the UK, expanding its prec...
Sanofi appoints new global head of Research & Development Pharma
23 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday the appointment of Paulo Fontoura, MD, PhD, FAAN, as executive vice president, global head of...
Lakewood-Amedex expands intellectual property portfolio with Australian Bisphosphocin patent
22 June 2026 - Biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ: LABT) announced on Monday that it has secured a new composition of matter patent from IP Australia covering its Bispho...
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
22 June 2026 - Replicate Bioscience, a clinical-stage company developing novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic are...